BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 14680955)

  • 1. In vitro protein refolding by chromatographic procedures.
    Li M; Su ZG; Janson JC
    Protein Expr Purif; 2004 Jan; 33(1):1-10. PubMed ID: 14680955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatographic methods for the isolation of, and refolding of proteins from, Escherichia coli inclusion bodies.
    Gu Z; Weidenhaupt M; Ivanova N; Pavlov M; Xu B; Su ZG; Janson JC
    Protein Expr Purif; 2002 Jun; 25(1):174-9. PubMed ID: 12071713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refolding and purification of rhNTA protein by chromatography.
    Fan X; Xu D; Lu B; Xia J; Wei D
    Biomed Chromatogr; 2009 Mar; 23(3):257-66. PubMed ID: 19101913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-column refolding and purification of transglutaminase from Streptomyces fradiae expressed as inclusion bodies in Escherichia coli.
    Liu XQ; Yang XQ; Xie FH; Song LY; Zhang GQ; Qian SJ
    Protein Expr Purif; 2007 Feb; 51(2):179-86. PubMed ID: 16935525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the refolding of NTA protein by urea gradient and arginine gradient size-exclusion chromatography.
    Fan X; Xu D; Lu B; Xia J; Wei D
    J Biochem Biophys Methods; 2008 Apr; 70(6):1130-8. PubMed ID: 18241925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High recovery refolding of rhG-CSF from Escherichia coli, using urea gradient size exclusion chromatography.
    Wang C; Wang L; Geng X
    Biotechnol Prog; 2008; 24(1):209-13. PubMed ID: 18179225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and on-column refolding of EGFP overexpressed as inclusion bodies in Escherichia coli with expanded bed anion exchange chromatography.
    Cabanne C; Noubhani AM; Hocquellet A; Dole F; Dieryck W; Santarelli X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(1):23-7. PubMed ID: 15722040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refolding and simultaneous purification of recombinant human proinsulin from inclusion bodies on protein-folding liquid-chromatography columns.
    Yuan J; Zhou H; Yang Y; Li W; Wan Y; Wang L
    Biomed Chromatogr; 2015 May; 29(5):777-82. PubMed ID: 25378200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renaturation, purification and characterization of streptokinase expressed as inclusion body in recombinant E. coli.
    Cherish Babu PV; Srinivas VK; Krishna Mohan V; Krishna E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(2):218-26. PubMed ID: 17981102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A medium or high throughput protein refolding assay.
    Cowieson NP; Wensley B; Robin G; Guncar G; Forwood J; Hume DA; Kobe B; Martin JL
    Methods Mol Biol; 2008; 426():269-75. PubMed ID: 18542870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysozyme refolding at high concentration by dilution and size-exclusion chromatography.
    Goa YG; Guan YX; Yao SJ; Cho MG
    J Zhejiang Univ Sci; 2003; 4(2):136-41. PubMed ID: 12659225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning, expression, and refolding of a secretory protein ESAT-6 of Mycobacterium tuberculosis.
    Wang BL; Xu Y; Wu CQ; Xu YM; Wang HH
    Protein Expr Purif; 2005 Feb; 39(2):184-8. PubMed ID: 15642469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On-column refolding of corticotropin-releasing factor receptor 1 extracellular domain by size exclusion chromatography.
    Ersoy M; Matic S; Schmidt SR
    Biomed Chromatogr; 2009 Oct; 23(10):1121-8. PubMed ID: 19404927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On-column refolding of recombinant human interleukin-4 from inclusion bodies.
    Razeghifard MR
    Protein Expr Purif; 2004 Sep; 37(1):180-6. PubMed ID: 15294296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct refolding of inclusion bodies using reversed micelles.
    Sakono M; Kawashima YM; Ichinose H; Maruyama T; Kamiya N; Goto M
    Biotechnol Prog; 2004; 20(6):1783-7. PubMed ID: 15575712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in in vitro refolding of inclusion body proteins].
    Fang M; Huang HL
    Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):608-12. PubMed ID: 11910749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration.
    Vallejo LF; Rinas U
    Biotechnol Bioeng; 2004 Mar; 85(6):601-9. PubMed ID: 14966801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An automatable screen for the rapid identification of proteins amenable to refolding.
    Cowieson NP; Wensley B; Listwan P; Hume DA; Kobe B; Martin JL
    Proteomics; 2006 Mar; 6(6):1750-7. PubMed ID: 16475229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation, solubilization, refolding, and chromatographic purification of human growth hormone from inclusion bodies of Escherichia coli cells: a case study.
    Singh SM; Eshwari AN; Garg LC; Panda AK
    Methods Mol Biol; 2005; 308():163-76. PubMed ID: 16082034
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Lin Z; Lei H; Cao P
    Protein Expr Purif; 2007 Feb; 51(2):276-82. PubMed ID: 17079165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.